Geode Capital Management, LLC Ocuphire Pharma, Inc. Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 468,937 shares of OCUP stock, worth $459,558. This represents 0.0% of its overall portfolio holdings.

Number of Shares
468,937
Previous 355,677 31.84%
Holding current value
$459,558
Previous $348,000 31.9%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
N/A
113,260 Added 31.84%
468,937 $459,000
Q2 2025

Aug 08, 2025
BUY
N/A
2,268 Added 0.64%
355,677 $348,000
Q1 2025

May 13, 2025
BUY
N/A
39,425 Added 12.56%
353,409 $346,000
Q4 2024

Feb 12, 2025
BUY
$0.88 - $1.35 $36,698 - $56,299
41,703 Added 15.32%
313,984 $307,000
Q3 2024

Nov 12, 2024
BUY
$1.19 - $2.07 $7,648 - $13,303
6,427 Added 2.42%
272,281 $356,000
Q2 2024

Aug 09, 2024
BUY
$1.51 - $2.23 $47,498 - $70,146
31,456 Added 13.42%
265,854 $406,000
Q1 2024

May 13, 2024
BUY
$1.89 - $3.27 $28,888 - $49,981
15,285 Added 6.98%
234,398 $471,000
Q3 2023

Nov 13, 2023
BUY
$3.35 - $4.33 $83,964 - $108,527
25,064 Added 12.92%
219,113 $734,000
Q2 2023

Aug 11, 2023
BUY
$3.63 - $6.38 $46,024 - $80,892
12,679 Added 6.99%
194,049 $842,000
Q1 2023

May 15, 2023
BUY
$3.01 - $3.85 $24,992 - $31,966
8,303 Added 4.8%
181,370 $680,000
Q4 2022

Feb 13, 2023
BUY
$2.04 - $3.53 $43,855 - $75,887
21,498 Added 14.18%
173,067 $610,000
Q3 2022

Nov 14, 2022
BUY
$1.82 - $2.79 $7,480 - $11,466
4,110 Added 2.79%
151,569 $304,000
Q2 2022

Aug 12, 2022
BUY
$1.8 - $3.25 $31,563 - $56,988
17,535 Added 13.5%
147,459 $283,000
Q1 2022

May 13, 2022
BUY
$2.75 - $4.39 $106,854 - $170,577
38,856 Added 42.67%
129,924 $420,000
Q4 2021

Feb 11, 2022
BUY
$3.4 - $5.19 $41,293 - $63,032
12,145 Added 15.39%
91,068 $339,000
Q3 2021

Nov 12, 2021
BUY
$3.84 - $5.38 $204,783 - $286,910
53,329 Added 208.37%
78,923 $406,000
Q2 2021

Aug 13, 2021
BUY
$4.24 - $6.57 $60,606 - $93,911
14,294 Added 126.5%
25,594 $135,000
Q1 2021

May 12, 2021
BUY
$5.7 - $13.31 $64,410 - $150,403
11,300 New
11,300 $65,000

Others Institutions Holding OCUP

# of Institutions
53
Shares Held
19.2M
Call Options Held
0
Put Options Held
0
View Full List

About Ocuphire Pharma, Inc.

OCUP Quotes by TradingView
  • Ticker OCUP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,579,800
  • Market Cap $20.2M
  • Description
  • Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...
More about OCUP
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email